Hemric Michael B.

Avg. Two Year Performance

512% Avg. Purchase Return
147% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return37%36%126%276%512%
Purchase Success Rate2 of 22 of 22 of 22 of 22 of 2
Average Sale Return----------
Sale Success Rate----------

Teligent, Inc.

Drugs » Biotechnology

Director:

Holdings: 73.52K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--